Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

If you’ve been suffering from a chronic or recurrent infection, you’re not alone. If it happens to be a urinary tract infection (UTI), the numbers may surprise you. It’s estimated that 150 million UTIs occur annually worldwide, accounting for more than $6 billion in healthcare costs.

We’re sharing a very personal story of one woman who has suffered from UTIs for much of her life. Now, about 45 years later, Raylene Billerbeck has finally found some relief.

MicroGenDX’s Next Generation DNA Sequencing delivers precise data for the diagnosis of infections with accurate microbial identification. Compared to traditional culture labs, Next Generation Sequencing (NGS) identifies 100 percent of the microbes within a sample with 99.9 percent accuracy. Plus, NGS detects antibiotic resistance genes for eight antibiotic classes, and delivers an antibiotic recommendations sheet.

Stay tuned to hear how MicroGenDX’s innovative testing technique has transformed Raylene’s life, and how NGS is shaking up the medical industry.

The Eversense is changing the game for people living with diabetes. This particular device is the first and only long-term CGM that lasts up to 90 days and is placed in your arm.

The Balancing Act returns with an all-new episode covering the latest on Broadway as well as a cutting-edge device improving the lives of those with type 1 diabetes.

On this edition of The Balancing Act, we're diving into fashion, travel, and the importance of taking control of your health. 

Comments

comments